Armata Pharmaceuticals Inc (ARMP): Next-Year EPS Estimate 64.78%
As of 2026-06-11, Armata Pharmaceuticals Inc (ARMP) has a next-year EPS growth estimate of 64.78%.
On 2026-05-28, analyst consensus for ARMP's next-year EPS growth shifted from 50.86% to 64.78% — a positive change of 13.92 percentage points. The revised estimate has been sustained across 11 subsequent trading sessions. Current-year growth is projected at 20.73%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 64.78%
- EPS growth this year
- 20.73%
- EPS next quarter (est)
- -$0.45
- Last price
- $7.47
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 64.78% | 20.73% | -$0.45 | $7.47 |
| 2026-06-10 | 64.78% | 20.73% | -$0.45 | $7.56 |
| 2026-06-09 | 64.78% | 20.73% | -$0.45 | $7.78 |
| 2026-06-08 | 64.78% | 20.73% | -$0.45 | $7.57 |
| 2026-06-07 | 64.78% | 20.73% | -$0.45 | $7.50 |
| 2026-06-04 | 64.78% | 20.73% | -$0.45 | $7.69 |
| 2026-06-03 | 64.78% | 20.73% | -$0.45 | $7.59 |
| 2026-06-02 | 64.78% | 20.73% | -$0.45 | $7.92 |
| 2026-06-01 | 64.78% | 20.73% | -$0.45 | $7.80 |
| 2026-05-31 | 64.78% | 20.73% | -$0.45 | $8.17 |
| 2026-05-28 | 64.78% | 20.73% | -$0.45 | $8.12 |
| 2026-05-27 | 50.86% | 39.58% | -$0.43 | $7.97 |
| 2026-05-26 | 50.86% | 39.58% | -$0.43 | $8.17 |
| 2026-05-25 | 50.86% | 39.58% | -$0.43 | $8.36 |
| 2026-05-24 | 50.86% | 39.58% | -$0.43 | $8.36 |
| 2026-05-21 | 50.86% | 39.58% | -$0.43 | $8.23 |
| 2026-05-20 | 50.86% | 39.58% | -$0.43 | $8.12 |
| 2026-05-19 | 50.86% | 39.58% | -$0.43 | $8.46 |
| 2026-05-18 | 50.86% | 39.58% | -$0.43 | $7.60 |
| 2026-05-17 | 50.86% | 39.58% | -$0.43 | $8.05 |
| 2026-03-25 | 33.33% | N/A | N/A | $8.61 |
| 2026-03-25 | 33.33% | N/A | N/A | $8.61 |
| 2026-03-25 | 33.33% | N/A | N/A | $8.61 |
| 2026-03-24 | 33.33% | N/A | N/A | $8.21 |
| 2026-03-24 | 33.33% | N/A | N/A | $8.21 |
| 2026-03-24 | 33.33% | N/A | N/A | $8.21 |
| 2026-03-23 | 33.33% | N/A | N/A | $8.09 |
| 2026-03-20 | 33.33% | N/A | N/A | $8.39 |
| 2026-03-19 | 33.33% | N/A | N/A | $8.29 |
| 2026-03-18 | 33.33% | N/A | N/A | $8.54 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Armata Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Armata Pharmaceuticals Inc (ARMP) has a next-year EPS growth estimate of 64.78%, based on analyst consensus.
When was the latest EPS estimate revision for ARMP?▾
The most recent revision occurred on 2026-05-28, when analysts adjusted the next-year EPS growth estimate from 50.86% to 64.78%.
What sector and industry does Armata Pharmaceuticals Inc belong to?▾
Armata Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ARMP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Armata Pharmaceuticals Inc (ARMP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports